Two Sigma Investments
BOLD

Two Sigma Investments’s Audentes Therapeutics, Inc BOLD Stock Holding History

Two Sigma Investments’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,003
Closed -$359K – 4142
2019
Q4 		$359K Sell
6,003
-15,083
-72% -$566K ﹤0.01% 3054
2019
Q3 		$592K Buy
21,086
+2,125
+11% +$72.5K ﹤0.01% 2415
2019
Q2 		$718K Buy
+18,961
New +$728K ﹤0.01% 2216
2018
Q3 		– Sell
-12,019
Closed -$459K – 3795
2018
Q2 		$459K Sell
12,019
-18,714
-61% -$693K ﹤0.01% 2706
2018
Q1 		$924K Sell
30,733
-97,974
-76% -$3.32M ﹤0.01% 2061
2017
Q4 		$4.02M Buy
128,707
+94,565
+277% +$2.6M 0.01% 1009
2017
Q3 		$956K Buy
+34,142
New +$741K ﹤0.01% 1748

Two Sigma Investments's BOLD Position: Q1 2020 in Review

Two Sigma Investments sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 6,003 shares — an estimated $359K sold.

Two Sigma Investments first reported a position in BOLD in Q3 2017 and held it in 7 quarters. The position peaked at $4.02M in Q4 2017. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Two Sigma Investments reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Two Sigma Investments sold 6,003 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $359K.
  • Two Sigma Investments first reported a position in Audentes Therapeutics, Inc in Q3 2017 and held it in 7 quarters.
  • Two Sigma Investments's Audentes Therapeutics, Inc position peaked at $4.02M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.